Amarantus Bioscience Holdings, Inc. — Form D

Amarantus Bioscience Holdings, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-09-13. The offering totals $5.0M, of which $1.4M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Mark E BenedykDirectorSUNNYVALE, CA
Dr. John W CommissiongDirectorSUNNYVALE, CA
Gerald E CommissiongDirectorSUNNYVALE, CA
Robert E HarrisDirectorSUNNYVALE, CA
Dr. John W CommissiongExecutive OfficerSUNNYVALE, CA
Gerald E CommissiongExecutive OfficerSUNNYVALE, CA
Marc E FaerberExecutive OfficerSUNNYVALE, CA
David LoweDirectorWalnut Creek, CA
Robert HarrisDirectorPotomac, MD
Robert FarrellExecutive OfficerNew York, NY
Iain RossDirectorLondon, X0
MARC FAERBERExecutive OfficerSANTA CRUZ, CA
Gerald CommissiongDirectorSan Francisco, CA
Gerald CommissiongExecutive OfficerSan Francisco, CA
Donald HuffmanDirectorSan Francisco, CA
John CommissiongDirectorSan Francisco, CA
John CommissiongExecutive OfficerSan Francisco, CA
Steven SpenceDirectorSan Francisco, CA
Robert L HarrisDirectorDallas, TX
Mark L BenedykDirectorSunnyvale, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2018-03-12D$1.5M$300K
2014-11-17D$3.0M$3.0M
2013-08-28D$1.3M$1.3M

More